Literature DB >> 1952565

Effect of DP-1904, a new thromboxane A2 synthetase inhibitor, on guinea pig experimental asthma.

M Takami1, Y Takata, K Matsumoto, S Ono, W Tsukada.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1952565     DOI: 10.1111/j.1749-6632.1991.tb37999.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  2 in total

1.  Pharmacokinetic-pharmacodynamic modelling of DP-1904, a novel thromboxane synthetase inhibitor in rabbits, based on an indirect response model.

Authors:  N X Zheng; H Sato; I Adachi; I Horikoshi
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Oct-Dec       Impact factor: 2.441

2.  A novel thromboxane synthetase inhibitor, DP-1904, inhibits human blood eosinophil degranulation.

Authors:  D K Agrawal; M Takami; S Ono
Journal:  Inflammation       Date:  1997-02       Impact factor: 4.092

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.